Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-20

Clinical Trial Update: A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating chlorhexidine as a treatment for vulvovaginal candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine (chlorhexidine)

Snippet

Sponsor: Karolinska Institutet | Conditions: Candidiasis, Vulvovaginal | Phase 2 | Status: UNKNOWN